100 likes | 114 Views
Guidance for Transplant Program Participation in the Transplantation of Non-A 1 /Non-A 1 B (A 2 /A 2 B) Donor Kidneys into Blood Group B Candidates. Minority Affairs Committee. What problem will the proposal solve?.
E N D
Guidance for Transplant Program Participation in the Transplantation of Non-A1/Non-A1B (A2/A2B) Donor Kidneys into Blood Group B Candidates Minority Affairs Committee
What problem will the proposal solve? • Transplant programs are unsure how to participate in KAS provision that will increase blood type B matches • Post-KAS implementation this provision has not reached full potential
What are the proposed solutions? Guidance created by a workgroup of Minority Affairs, Kidney, and the Transplant Administrators Committee members to create program best practices including: • Suggested titer thresholds • How to develop informed consent policy • How to determine and maintain patient eligibility
How will members implement this proposal? • Kidney programs should consider this guidance if they choose perform transplantsof non-A1/non-A1B (A2/A2B) donor kidneys into blood group B candidates • Guidelines are voluntary and not prescriptive of clinical practice
How will the OPTN implement this proposal? • Anticipated Board of Directors Review: Dec. 2017 • If approved, resource available on OPTN website and Transplant Pro • Complementary instructional program, highlighting established programs successfully performing these transplants, will be developed
Questions? Sylvia Rosas, MD, MSCE Minority Affairs Committee Chair Sylvia.Rosas@joslin.harvard.edu Emily Ward, MPA Minority Affairs Committee Liaison Emily.Ward@unos.org
Supporting Evidence: Selected 2016 MAC Survey Results Figure 1: Which of the following could help you establish an A2/A2B into B blood type protocol at your center?
Guidance Summary Chart: Non-A1/non-A1B (A2/A2B) Protocol Development Recommendations